In this study, the effects of aPDT on the immune system of G. mellonella were not investigated. Therefore, future studies need to be developed to understanding the action of aPDT and methylene blue in the haemocyte density and in the expression of a variety of antimicrobial peptides involved in immune responses of G. mellonella. The key conclusion is that the G. mellonela

– C. albicans system is a suitable model to study antifungal PDT and to explore combinatorial aPDT-based treatments. Thus, this invertebrate animal model host provides a novel approach to assess the effects of in vivo PDT, alone or in combination with antifungal compounds, on fungal 3-deazaneplanocin A ic50 infections without the difficulties of mammalian models. Acknowledgments José Chibebe Junior thanks CAPES (PDEE 2507-11-0) for the scholarship during the PhD Program at Harvard Medical School. Xiaojiang Tan was EPZ5676 clinical trial supported by Science and Technology Planning Project of Guangdong Province, P.R. China (2011B080701091). Juliana C Junqueira thanks São Paulo Council selleck kinase inhibitor of Research – FAPESP, Brazil (grant 12/19915-6). Research conducted in the Mylonakis

Laboratory was supported by NIH (RO1 AI050875 to EM). Research conducted in the Hamblin Laboratory was supported by NIH (RO1 AI050875 to MRH) and US Air Force MFEL Program (FA9550-04-1-0079). George P Tegos was supported by the NIH (grant 5U54MH084690-02). References 1. Chabrier-Rosello Y, Giesselman BR, De Jesus-Andino FJ, Foster TH, Mitra S, Haidaris CG: Inhibition of electron transport chain assembly and function promotes photodynamic killing of Candida . J Photochem Photobiol

B 2010, 99:117–125.PubMedCrossRef 2. Thein ZM, Seneviratne CJ, Samaranayake YH, Samaranayake LP: Community lifestyle of Candida in mixed biofilms: a mini review. Mycoses 2009, 52:467–475.PubMedCrossRef 3. Junqueira JC, Fuchs BB, Muhammed M, Coleman JJ, Suleiman JM, Vilela SF, Costa AC, Rasteiro VM, Jorge AO, Mylonakis E: Oral Candida albicans isolates from HIV-positive individuals have similar in vitro biofilm-forming ability and pathogenicity as invasive Candida isolates. BMC Microbiol 2011, 11:247.PubMedCrossRef 4. Cowen LE, Atezolizumab cost Singh SD, Kohler JR, Collins C, Zaas AK, Schell WA, Aziz H, Mylonakis E, Perfect JR, Whitesell L, et al.: Harnessing Hsp90 function as a powerful, broadly effective therapeutic strategy for fungal infectious disease. Proc Natl Acad Sci USA 2009, 106:2818–2823.PubMedCrossRef 5. Douglas LJ: Candida biofilms and their role in infection. Trends Microbiol 2003, 11:30–36.PubMedCrossRef 6. Dai T, Fuchs BB, Coleman JJ, Prates RA, Astrakas C, St Denis TG, Ribeiro MS, Mylonakis E, Hamblin MR, Tegos GP: Concepts and principles of photodynamic therapy as an alternative antifungal discovery platform. Front Microbiol 2012, 3:120.PubMedCrossRef 7.